TAK-137

CAS No. 1358749-55-9

TAK-137( —— )

Catalog No. M36358 CAS No. 1358749-55-9

TAK-137 is an AMPA receptor enhancer with antidepressant effects. TAK-137 has the ability to improve cognition and could be used to study schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TAK-137
  • Note
    Research use only, not for human use.
  • Brief Description
    TAK-137 is an AMPA receptor enhancer with antidepressant effects. TAK-137 has the ability to improve cognition and could be used to study schizophrenia.
  • Description
    TAK-137 is an AMPA receptor enhancer with antidepressant effects. TAK-137 has the ability to improve cognition and could be used to study schizophrenia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1358749-55-9
  • Formula Weight
    352.41
  • Molecular Formula
    C19H16N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S1(=O)N=C2C(=CC=CN2CC1)C=3C=CC(OC=4C=CC=CC4)=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tulrampator

    Tulrampator (S 47445;CX 1632) is a novel potent, selective, positive allosteric modulator of AMPA receptor (AMPAR) with EC50 of 2.5-5.4 uM for different AMPA receptors subtypes.

  • GYKI 52466 dihydroch...

    GYKI 52466 is a selective, non-competitive, orally active AMPA receptor (AMPAR) antagonist with IC50 of 10-20 uM against AMPA-induced responses.

  • Gavestinel sodium

    Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.